Ultra Dynamic Quality Systems (UDQS) supports pharmaceutical manufacturers across Africa in establishing supplier qualification systems aligned with WHO GMP guidelines, international regulatory standards, and best practices for pharmaceutical supply chain management.
Pharma 4.0 refers to the digital transformation of pharmaceutical manufacturing through the integration of smart technologies and connected systems.
The goal of Pharma 4.0 is to create data-driven manufacturing environments where production processes can be continuously monitored, optimized, and controlled.
One of the most important pathways to entering these markets is through the World Health Organization (WHO) Prequalification Programme (PQ).
Stability studies ensure pharmaceutical products remain safe and high quality throughout their shelf life by evaluating the impact of environmental conditions, supporting regulatory compliance and guiding storage, packaging and expiry decisions
In pharmaceutical and biopharmaceutical manufacturing, validation is a critical component of Good Manufacturing Practice (GMP). It provides…
In modern pharmaceutical manufacturing, preventing contamination is one of the most critical responsibilities of any production facility. Contamination can compromise product quality, endanger patient safety, and lead to serious regulatory consequences.
In pharmaceutical manufacturing, the design of a facility is one of the most critical determinants of regulatory compliance, operational efficiency, and product quality. Unlike many industrial facilities, pharmaceutical plants must be built around strict principles of contamination control, controlled environments, and validated processes.